# Osteogenic shift in the adipose-derived stem cells of Acomys cahirinus is linked to impaired adipose tissue self-renewal

**Authors:** M. Boldyreva, E. Zubkova, E. Trubkina, M. Agareva, S. Michurina, N. Alekseeva, I. Beloglazova, E. Ratner, Ye Parfyonova, I. Stafeev

PMC · DOI: 10.3389/fcell.2025.1603405 · 2025-07-30

## TL;DR

This study explores how fat stem cells from Acomys cahirinus may help maintain metabolic health during obesity by shifting toward bone formation instead of fat.

## Contribution

The paper reveals a unique osteogenic shift in Acomys cahirinus ADSC linked to impaired adipose tissue self-renewal.

## Key findings

- Acomys cahirinus ADSC show enhanced osteogenesis and suppressed adipogenesis.
- Acomys cahirinus has larger fat depots and lower blood glucose compared to mice.
- Reduced ATGL expression in Acomys cahirinus adipose tissue may protect against excessive fat accumulation.

## Abstract

In recent years, there has been a significant increase in interest in Acomys cahirinus due to their unique regenerative properties and specific metabolism. We propose that Acomys sp. adipose-derived stem cells (ADSC) may have unique properties allowing them to adapt to caloric overload and prevent severe metabolic abnormalities. ADSC characterization from Acomys cahirinus may reveal novel pro-regenerative targets and provide insight into mechanisms enabling the maintenance of metabolic health during obesity.

ADSCs were isolated from the subcutaneous fat depots of Acomys cahirinus and Mus musculus, which was used as a classic lab animal rodent model. The mesenchymal phenotype of ADSC was confirmed by surface markers expression and differentiation ability. Proliferation and migration of ADSC were assessed by metabolic tests and microscopy. Osteogenesis and adipogenesis were evaluated by specific staining and RT PCR gene expression analysis. Subcutaneous adipose tissue was characterized by histology and Western blotting.

Acomys cahirinus ADSC exhibited classic mesenchymal phenotype. Proliferation and wound healing were more active in Acomys cahirinus ADSC. These ADSC demonstrated enhanced osteogenesis and suppressed adipogenesis. Acomys cahirinus has larger adipose tissue depots than Mus musculus and lower blood glucose level. Acomys cahirinus adipose tissue is distinguished by lowered proliferation, enlarged adipocytes and suppressed adipose tissue triglyceride lipase (ATGL) expression.

We conclude that Acomys cahirinus ADSC have high regenerative potential. Nevertheless, the augmented osteogenic capacity of Acomys cahirinus ADSC can be related with a limited ADSC participation in adipose tissue self-renewal. The reduction in ATGL expression observed in Acomys cahirinus adipose tissue may serve as a protective mechanism in the face of excessive adipose tissue accumulation.

## Linked entities

- **Genes:** PNPLA2 (patatin like domain 2, triacylglycerol lipase) [NCBI Gene 57104]
- **Species:** Acomys cahirinus (taxon 10068), Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Irs1 (insulin receptor substrate 1) [NCBI Gene 16367] {aka G972R, IRS-1}, Pcna (proliferating cell nuclear antigen) [NCBI Gene 18538], Pnpla2 (patatin-like phospholipase domain containing 2) [NCBI Gene 66853] {aka 0610039C21Rik, 1110001C14Rik, Atgl, TTS-2.2}, Fabp4 (fatty acid binding protein 4, adipocyte) [NCBI Gene 11770] {aka 422/aP2, AFABP, ALBP, ALBP/Ap2, Ap2, Lbpl}
- **Diseases:** metabolic abnormalities (MESH:D008659), glucose metabolism abnormalities (MESH:D044882), non-alcoholic fatty liver disease (MESH:D065626), neurodegenerative disease (MESH:D019636), Fat (MESH:D004620), glucose intolerance (MESH:D018149), dislocation (MESH:D004204), type 2 diabetes (MESH:D003924), adiposity (MESH:D018205), Diabetes (MESH:D003920), obese (MESH:D009765), hypertrophy (MESH:D006984), hyperplasia (MESH:D006965), osteogenesis (MESH:D010013), ADSC (MESH:D000092423), hyperglycemia (MESH:D006943), peripheral artery disease (MESH:D058729)
- **Chemicals:** MTT (MESH:C070243), phenol red (MESH:D010637), Alizarin Red S (MESH:C004468), water (MESH:D014867), Blood glucose (MESH:D001786), ethanol (MESH:D000431), isoflurane (MESH:D007530), citrate (MESH:D019343), methanol (MESH:D000432), calcium (MESH:D002118), Hematoxylin (MESH:D006416), isopropanol (MESH:D019840), Triton X-100 (MESH:D017830), glucose (MESH:D005947), ATP (MESH:D000255), Alexa Fluor 488 (MESH:C000711379), fatty acid (MESH:D005227), rosiglitazone (MESH:D000077154), paraffin (MESH:D010232), agarose (MESH:D012685), BODIPY493/503 (MESH:C527198), formazan (MESH:D005562), IBMX (MESH:D015056), SYBR-green (MESH:C098022), SDS (MESH:D012967), Alcian Blue (MESH:D000423), eosin (MESH:D004801), dexamethasone (MESH:D003907), hydrogen peroxide (MESH:D006861), PVDF (MESH:C024865), T3 (MESH:D014284), xylene (MESH:D014992), 3, 3-diaminobenzidine (MESH:D015100), Alexa Fluor 647 (MESH:C569686), lipid (MESH:D008055), glycosaminoglycans (MESH:D006025), BODIPY493 (-), eosin B (MESH:D010697), triglyceride (MESH:D014280), 4',6-diamidino-2-phenylindole (MESH:C007293), T4 (MESH:D013974), sodium ascorbate (MESH:D001205), CO2 (MESH:D002245), DPBS (MESH:C012939), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MESH:C022616), paraformaldehyde (MESH:C003043)
- **Species:** Homo sapiens (human, species) [taxon 9606], Acomys (spiny mice, genus) [taxon 10067], Acomys cahirinus (Cairo spiny mouse, species) [taxon 10068], Rattus norvegicus (brown rat, species) [taxon 10116], Acomys sp. (species) [taxon 60743], Rodentia (rodent, order) [taxon 9989], Mus musculus (house mouse, species) [taxon 10090], Hermetia illucens (black soldier fly, species) [taxon 343691]
- **Cell lines:** C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), /6J — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_W797)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12343677/full.md

---
Source: https://tomesphere.com/paper/PMC12343677